Peg-Interferon Plus Ribavirin with or without Boceprevir or Telaprevir for HCV Genotype 1: A Meta-Analysis on the Role of Response Predictors

BACKGROUND & AIM: To compare the efficacy of pegylated-interferon (Peg-IFN) α-2a or α-2b and ribavirin given as dual therapy versus triple therapy (Peg-IFN and ribavirin plus boceprevir or telaprevir) in patients with HCV-1 chronic hepatitis naïve for anti-HCV therapy or relapsers to dual therap...

Descripción completa

Detalles Bibliográficos
Autores principales: Coppola, Nicola, Pisaturo, Mariantonietta, Sagnelli, Caterina, Sagnelli, Evangelista, Angelillo, Italo F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3984165/
https://www.ncbi.nlm.nih.gov/pubmed/24728219
http://dx.doi.org/10.1371/journal.pone.0094542

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3984165/
https://www.ncbi.nlm.nih.gov/pubmed/24728219
http://dx.doi.org/10.1371/journal.pone.0094542

Ejemplares similares